Brief: Eagle Pharmaceuticals Reaches Settlement With Dr. Reddy's Laboratories Inc, Dr. Reddy's Laboratories Ltd Related To Bendeka (Bendamustine Hydrochloride)
05/04/2023 12:07
April 5 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS REACHES SETTLEMENT AGREEMENT WITH
DR.
REDDY’S LABORATORIES INC. AND DR. REDDY’S LABORATORIES LTD.
RELATED TO BENDEKA® (BENDAMUSTINE HYDROCHLORIDE)
* EAGLE PHARMACEUTICALS INC - SETTLEMENT AGREEMENT IS
CONFIDENTIAL
* EAGLE PHARMACEUTICALS - UNDER SETTLEMENT AGREEMENT, DR.
REDDY'S
HAS RIGHT TO MARKET PRODUCT BEGINNING NOVEMBER 17, 2027
Source text for Eikon: ID:nGNX99Y45Z
Further company coverage: EGRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq